9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder

RALEIGH, NC / ACCESSWIRE / March 2, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced

Related Keywords

Al Medwar ,Patrickh Griffin ,Gregg Silverman ,Veronica Eames ,Langone Health ,Linkedin ,Langone Judith Stewart Colton Center ,Meters Biopharma Inc ,Nasdaq ,Company Annual Report On Form ,Colton Center ,Lifesci Communications ,Investor Relations Corporate Communications ,Chief Medical Officer ,Stewart Colton Center ,Annual Report ,Investor Relations ,Sci Communications ,Meters ,Iopharma ,Nnounces ,Collaboration ,Langone ,Health ,Nvestigating ,Potential ,Treatment ,Autoimmune ,Disorder ,